Abbott’s Synthroid Faces Removal

Follow my blog with Bloglovin

The Food and Drug Administration has told the makers of Synthroid, the third most frequently prescribed drug in the U.S., that the medicine has a “history of problems” and cannot be recognized as “safe and effective.”The agency’s statements raise the possibility that the 40-year-old drug, which has never been officially approved for use by the FDA, will be subject to regulatory action that could, in the extreme, include removal from the market — a process that could begin as early as August. Synthroid went on the market more than four decades ago and never received formal approval from the FDA.Four years ago, the FDA said that makers of thyroid drugs like Synthroid, known generically as levothyroxine sodium, needed to get FDA approval for the drugs to continue marketing them.Abbott Laboratories, which acquired Synthroid’s maker earlier this year, has said it will submit an application to the FDA detailing the drug’s safety and efficacy and that it is confident the drug will be allowed to stay on the market.

The company said this week that its reading of FDA notices indicated that it had to submit its application to the agency by Aug. 14.But a spokeswoman for the FDA said the regulatory notices the agency has published on Synthroid and its competitors “don’t include a provision” related to simply submitting an application by Aug. 14. The agency has not decided what it would do if the Aug. 14 deadline came and went before the drug received approval.

But it would not rule out asking for the drug’s removal and noted that there are two other approved drugs in Synthroid’s class that could fill any void left by Synthroid.Two other drugs — Levoxyl from King Pharmaceuticals Inc. and Unithroid from Watson Pharmaceuticals Inc. and Jerome Stevens Pharmaceuticals Inc. — have applied for and received approval from the FDA. “We understood that we had to have an approval by Aug. 14, 2001, and we still understand that to be the case,” said James Green, a spokesman for King.

“Of course, we are approved now. We take comfort in that.”

Best Steroids

dragon-pharmaceutical
Dragon Pharma is a pharmaceutical company: Anavar for Sale – manufacturing and exporting from Europe.

Best Steroids

Dragon Pharma is manufacturing a large range of steroids Oxymetholon for Sale.

Buy Dragon Pharma Labs Overseas

Cut Long 300

Injectable Anabolic Steroid
Basic Component: Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Made by: Dragon Pharmaceutical
Unit: 1 X 10 ml (300 mg/ml)

1-Test Cyp 200

Injectable Anabolic Steroid
Main Chemical Name: Dihydroboldenone Cypionate
Made by: Dragon Pharma Labs
Pack: 1 X 10 mL vial (200 mg/mL)

EQ 300 - Cheap Price

Administration: Injection
Basic Substance: Boldenone Undecylenate
Manufacturer: Dragon Pharma
Pack: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Cypionat 250 - Cheap Price

Administration: Injection
Main Component: Testosterone Cypionate
Made by: Dragon Pharmaceutical
Amount: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Turanabol - Cheap Price

Administration: Oral
Basic Chemical Name: Chlorodehydromethyltestosterone
Producer: Dragon Pharma
Package: 20 x 100 pills (10 mg/pastille)
Price: 20 x $60.00

Trenbolone 100 - Bulk Price

Administration: Injection
Principal Chemical Name: Trenbolone Acetate
Producer: Dragon Pharmaceuticals
Unit: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $60.00

Dianabol 20 - Discount Price

Administration: Oral
Main Ingredient: Methandrostenolone
Manufacturer: Dragon Pharma LLC
Amount: 30 x 100 pastilles (20 mg/tablet)
Price: 30 x $26.00

EQ 200 / Test E 200

Injectable Anabolic Steroid
Basal Ingredient: Boldenone Undecylenate, Testosterone Enanthate
Made by: Dragon Pharma LLC
Pack: 1 X 10 mL vial (400 mg/mL)

Masteron 100 [10 Vials]

Injectable Steroid for Muscle Growth
Main Ingredient: Drostanolone Di-Propionate
Branded by: Dragon Pharma
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $49.00 = $490.00 in Total

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Base Component: Boldenone Undecylenate
Branded by: Dragon Pharma LLC
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

Nolvadex

Main Constituent: Tamoxifen Citrate
Produced by: Dragon Pharma
Package: 100 pills (20 mg/pastille)

Deca 300

Active Constituent: Nandrolone Decanoate
Producer: Dragon Pharmaceuticals
Package: 10 mL vial (300 mg/mL)